10-K/A: IN8bio Files Amendment No. 1 to Form 10-K to Correct Exhibit List and Include Updated Certifications

IN8bio, Inc. files an amendment to its annual report on Form 10-K to correct the exhibit list and include new certifications from its principal executive and financial officers.

Summary

• IN8bio, Inc. is filing Amendment No. 1 to its Annual Report on Form 10-K.
• The amendment corrects the exhibit list in Item 15 of Part IV of the initial filing.
• New certifications from the principal executive officer and principal financial officer are included, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
• The company's common stock is traded on the Nasdaq Stock Market LLC under the ticker symbol INAB.
• As of May 2, 2025, there were 90,771,944 shares of the company's common stock outstanding.
• The aggregate market value of voting and non-voting common equity held by non-affiliates was approximately $29.0 million as of June 28, 2024, based on a closing price of $0.85 per share.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing, indicating standard corporate governance practices. The sentiment is neutral to slightly positive as it reflects adherence to compliance requirements.

Positives

• The company is taking steps to ensure compliance with SEC regulations by correcting the exhibit list and including updated certifications.

Management Comments

• Patrick McCall, Chief Financial Officer & Secretary, certified the accuracy of the report.
• William Ho, Chief Executive Officer, certified the accuracy of the report.

Industry Context

This is a standard regulatory filing update, ensuring compliance with SEC requirements for publicly traded companies.

Stakeholder Impact

• The filing ensures transparency and accuracy in financial reporting, which is important for shareholders.

Key Dates

Keywords

Form 10-K/A, amendment, IN8bio, certifications, exhibit list, financial reporting, SEC filing